期刊
CURRENT RHEUMATOLOGY REPORTS
卷 21, 期 4, 页码 -出版社
SPRINGER
DOI: 10.1007/s11926-019-0811-3
关键词
Immune checkpoint inhibitor; Programed cell death-1; Cytotoxic T lymphocyte antigen 4; Autoreactive T cell; Myositis
类别
资金
- Ministry of Health, Labour and Welfare, Japan
Purpose of the ReviewWe clarify clinical characteristics of patients with immune checkpoint inhibitor (ICI)-induced myositis.Recent FindingsIn 13 of 15 cases with ICI-induced myositis, the type of malignancy was melanoma. Eight, 4, and 3 patients received anti-PD-1 alone, anti-CTLA4 alone, and a combination of those, respectively. The mean period to the onset of ICI-induced myositis from the initiation of ICI was 4weeks. Myocarditis was a complication in five patients. Seven of the patients died. The causes of death were myocarditis in three patients, respiratory muscle paralysis in two patients, and cancer progression in two patients. In patients without myocarditis or respiratory muscle paralysis, the prognosis for myositis was favorable with normalization of the CK levels occurring upon the cessation of ICI and the administration of immunosuppressive agents.SummaryMyocarditis and respiratory muscle paralysis are the major causes of death as immune-related adverse events in patients with ICI-induced myositis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据